A randomized, double-blind, phase I dose-escalation study of the novel retinoid 9CUAB30
Ended Awarded Last action
- Contract number
- HHSN26100007
- Awardee
-
University Of Wisconsin System UEI LCLSJAGTNZQ7 Part of University Of Wisconsin System
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $261,352
Award facts
- Opportunity
-
- N01CN0501469 Solicitation number
- Cancer Prevention Agent Development Program: Early Phase Clinical Research Award Notice · Posted Mar 4, 2011
- Contract value 100% obligated
- $261,352.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Madison, WI 53715, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$6,226 | |
| Other Administrative Action | $0 | |
| Original award | $267,578 |
About this award
The National Cancer Institute issued a delivery order to the University of Wisconsin System on July 1, 2015, with a ceiling value of $261,352 under the Cancer Prevention Agent Development Program 2012-2017.
The order funds a randomized, double-blind, Phase I dose-escalation study of the novel retinoid 9CUAB30, a cancer prevention agent under early-phase clinical research. Place of performance is Madison, Wisconsin. The order is priced on a cost, no-fee basis and has an ultimate completion date of March 31, 2017.
Quick answers
Who was awarded contract HHSN26100007?
HHSN26100007 was awarded to University Of Wisconsin System by National Cancer Institute (National Institutes of Health) on July 1, 2015.
How much is contract HHSN26100007 worth?
The government has obligated $261,352 on HHSN26100007.
Is contract HHSN26100007 an order under another contract?
Yes. HHSN26100007 is a delivery order under HHSN261201200033I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.
Was contract HHSN26100007 competed?
The extent of competition for HHSN26100007 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award